Parmax Pharma Limited reported audited earnings results for the fourth quarter and full year ended of March 31, 2017. For the quarter, the company reported total income from operations (net) of INR 150,000 compared to INR 600,000 a year ago. Profit before exceptional and extra ordinary items & taxes were INR 34,556 compared to INR 332,112 a year ago. Profit from ordinary activities before tax was INR 34,556 compared to INR 332,112 a year ago. Profit for the period was INR 34,556 compared to INR 332,112 a year ago. Basic earnings per share was INR 0.01 compared to INR 0.09 a year ago. For the full year, the company reported total income from operations (net) of INR 600,000 compared to INR 600,328 a year ago. Profit before exceptional and extra ordinary items & taxes were INR 51,213 compared to INR 114,310 a year ago. Profit from ordinary activities before tax was INR 51,213 compared to INR 97,127 a year ago. Loss for the period was INR 78,787 compared to INR 37,873 a year ago. Basic earnings per share was INR 0.02 compared to INR 0.01 a year ago.